← Open Payments lookup

CHELSEA VILICICH: Open Payments

NPI 1003408113 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,351 in 142 payments from 19 companies in 2025. Trend: 2023 $3,637 · 2024 $3,421 · 2025 $3,351

Food & beverage: $3,351
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.19$561
Vanda Pharmaceuticals Inc.16$521
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$479
Otsuka America Pharmaceutical, Inc.13$330
Janssen Pharmaceuticals, Inc6$178
Bausch Health US, LLC8$161
Axsome Therapeutics, Inc.7$158
Alkermes, Inc.11$147
Lundbeck LLC7$143
E.R. Squibb & Sons, L.L.C.4$120

Products named: INGREZZA, CAPLYTA, HETLIOZ, ABILIFY ASIMTUFII, REXULTI, SPRAVATO, APLENZIN, Auvelity.

Industry payments across CA — which companies pay providers there.